← Leaderboards
Maureen C Ferran
University Of Rochester
$878,354
Attributed
$1,098,806
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $451.2K · FY2021–24$500K$375K$250K$125K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$1,098,806 · 3
By mechanism
R15$657,901 · 2
R21$440,905 · 1
Top collaborators
- Andrew Vaughn Samuelson4 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Roman Jeno Giger$6,971,296
- Hajime Hirase$761,969
- Andrew Vaughn Samuelson$4,466,913
- Clyde Thomas Overby$138,308
- Sanjeev Sahni$7,094,320
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingCellsGenesTechnologyVirusGene ExpressionVesicular Stomatitis Indiana VirusGenetic AnalysisFeedingGenetic ApproachDisciplineBiological SystemsExpression VectorGeneticAnimalsBiological ModelsGene DiscoveryCommunitiesAccelerationGene Delivery SystemFunctional GenomicsAreaClustered Regularly Interspaced Short Palindromic RepeatsCaenorhabditis Elegans
Grant awards (6)
Viral vector-mediated gene activation to facilitate large-scale genetic analysis in Caenorhabditis elegans.$185,620
R21 · FY2024 · GM
Viral vector-mediated gene activation to facilitate large-scale genetic analysis in Caenorhabditis elegans.$31,005
R21 · FY2024 · GM
Viral vector-mediated gene activation to facilitate large-scale genetic analysis in Caenorhabditis elegans.$205,192
R21 · FY2023 · GM
Viral vector-mediated gene activation to facilitate large-scale genetic analysis in Caenorhabditis elegans.$19,088
R21 · FY2023 · GM
NFkB-dependent antiviral pathways in VSV-resistant cancer cells$451,178
R15 · FY2021 · CA · contact PI
Interferon Gene Expression in VSV-Infected Cells$206,723
R15 · FY2004 · AI